Principal Technologies (TSXV:PTEC) Tax Provision : C$-0.05 Mil (TTM As of Jan. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Principal Technologies Tax Provision?

Principal Technologies's tax provision for the three months ended in Jan. 2025 was C$-0.01 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jan. 2025 was C$-0.05 Mil.

Principal Technologies Tax Provision Historical Data

The historical data trend for Principal Technologies's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Principal Technologies Tax Provision Chart

Principal Technologies Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Tax Provision

-0.04

-0.01

-0.03

Principal Technologies Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Tax Provision	Get a 7-Day Free Trial															-	-0.01	-0.01	-0.02	-0.01

Principal Technologies Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05 Mil.

Principal Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Principal Technologies Inc (TSXV:PTEC) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 West Georgia Street, Suite 2500, Vancouver, BC, CAN, V7Y 1B3

Website

https://www.principal-technologies.com

Principal Technologies Inc focuses on investment in a healthcare technology company. It is building a diverse portfolio of investments in healthcare technology companies with a focus on those with distribution potential across the world, and have intellectual property capable of enhancing medical treatment, cost efficiency, optimizations of the patient pathway, and implementation of point-of-care technologies. The company operates in one reportable operational segment, being its operations in healthcare technology including the project management of international-scale clinical studies predominantly related to medical device technologies.

Executives

John William Mccoach

Director